Investors Have Chance to Take Charge in Kyverna Therapeutics Securities Fraud Case
Kyverna Therapeutics Class Action Opportunity
Investors Alert: If you purchased common stocks of Kyverna Therapeutics, Inc., now is a pivotal moment. The Rosen Law Firm, renowned for protecting investor rights, has announced a class action lawsuit related to securities fraud tied to Kyverna's IPO that was held on February 8, 2024. The firm is encouraging potential claimants to participate in this legal action by filing claims before the February 7, 2025 deadline.
What Occurred?
Kyverna Therapeutics conducted its IPO and subsequently faced scrutiny as allegations emerged concerning misrepresentations in its registration statement and prospectus. Specifically, the lawsuit contends that the company expressed certain